Shanghai Medicilon Company Description

Shanghai Medicilon Inc., a contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally.

The company operates in Drug Discovery and Pharmaceutical Research, and Preclinical Research segments.

It offers drug discovery, CMC development, preclinical research, biology, chemistry, catalyst screening, flow chemistry, carbohydrate chemistry, analytical chemical, ADME/DMPK, pharmacology, safety assessment, IND-Enabling studies, and advanced technology services.

The company also provides peptide, SiRNA, ADC, Protac, AOCs, NAMs Platforms. The company was founded in 2004 and is based in Shanghai, China.

Shanghai Medicilon Inc.

Country	China
Founded	2004
Industry	Biotechnology
Sector	Healthcare
Employees	2,504
CEO	Chunlin Chen

Contact Details

Address: No. 585, Chuanda Road Shanghai, 201299 China
Phone	86 21 5859 1500
Website	medicilon.com.cn

Stock Details

Ticker Symbol	688202
Exchange	Shanghai Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE100003NQ8
SIC Code	8731

Key Executives

Name	Position
Jianglin Hu	Joint Chief Executive Officer, Executive Vice President and Chief Strategy and Development Officer
Dr. Chun-Lin Chen Ph.D.	Co-Founder, Chairman and Chief Executive Officer
Shuangqing Peng Ph.D.	Chief Scientific Officer
Dr. Jinna Cai Ph.D.	Chief Commercial Officer, Deputy GM and Director
Binbin Liu	Deputy General Manager
Donghua Zhang	Financial Director
Fang Hong Chen	Accounting Supervisor
Dr. Lilly Xu Ph.D.	Chief Technology Officer
Jiang Xu MBA	Manager of Human Resources Department
Dr. Haizhou Zhang	President of Preclinical Research & Development Unit